The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Large Molecule Bioanalytical Service Market Research Report 2024
Synopsis
Large molecule bioanalysis is an arena of analytical chemistry and bio chemistry in which large molecule-like proteins therapeutics are studied and examined in the biological atmosphere to understand the behavior of the molecule. The therapeutic analysis includes pharmacodynamics and pharmacokinetic studies, and immunological testing, and biomarker assays to offers treatment and onset of action of a particular drug in the human body.
Global Large Molecule Bioanalytical Service market is projected to reach US$ 515.6 million in 2029, increasing from US$ 415 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Large Molecule Bioanalytical Service market research.
The global large molecule bioanalytical service market refers to the market for specialized analytical services related to the analysis and characterization of large molecules, such as proteins, antibodies, peptides, and nucleic acids. These services are crucial in various stages of drug development, from preclinical research to clinical trials and post-marketing studies, to ensure the safety, efficacy, and quality of large molecule therapeutics. The large molecule bioanalytical service market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals and biologics has generated a need for robust analytical methods to assess the pharmacokinetics, metabolism, and immunogenicity of these complex molecules. As large molecule therapeutics become more prevalent in treating various diseases, the demand for bioanalytical services to support their development and regulatory approval is on the rise. Secondly, regulatory agencies across the world, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have stringent guidelines and requirements for the characterization and analysis of large molecule drugs. These regulations necessitate the use of validated and robust bioanalytical methods to generate accurate and reliable data. Hence, pharmaceutical and biotechnology companies rely on specialized bioanalytical service providers with expertise in large molecule analysis to meet these regulatory requirements. Thirdly, advancements in technology and analytical techniques have expanded the capabilities of large molecule bioanalysis. Techniques such as liquid chromatography-mass spectrometry (LC-MS), enzyme-linked immunosorbent assay (ELISA), and ligand binding assays (LBAs) have enabled more precise and sensitive analysis of large molecules. The availability of these advanced technologies has further fueled the demand for specialized bioanalytical services. In terms of market segmentation, the large molecule bioanalytical service market can be divided based on the type of service provided, such as method development, validation, sample analysis, and pharmacokinetic analysis. Service providers in this market offer tailored solutions to meet the specific needs of drug developers and research organizations. Geographically, North America dominates the global large molecule bioanalytical service market, owing to the presence of major pharmaceutical and biotechnology companies, well-established research infrastructure, and stringent regulatory standards. Europe is also a significant market for these services, supported by the presence of top pharmaceutical companies and a robust clinical research environment. Emerging economies in Asia Pacific and Latin America are witnessing growth in the market as the biopharmaceutical industry expands and regulatory frameworks strengthen.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Large Molecule Bioanalytical Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intertek Group plc.
Solvias AG
Bio-Techne Corporation
Wyatt Technology Corporation
Precision NanoSystems
Verder
Halo Labs
Charles River Laboratories International, Inc.
Avomeen
Merck KGaA
Cergentis B.V.
Laboratory Corporation of America Holdings
SCIEX
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Segment by Type
Pharmacokinetic (PK) Testing
Pharmacodynamics (PD) Testing
Immunogenicity Testing
Biomarker Assay
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Large Molecule Bioanalytical Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Large molecule bioanalysis is an arena of analytical chemistry and bio chemistry in which large molecule-like proteins therapeutics are studied and examined in the biological atmosphere to understand the behavior of the molecule. The therapeutic analysis includes pharmacodynamics and pharmacokinetic studies, and immunological testing, and biomarker assays to offers treatment and onset of action of a particular drug in the human body.
Global Large Molecule Bioanalytical Service market is projected to reach US$ 515.6 million in 2029, increasing from US$ 415 million in 2022, with the CAGR of 3.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Large Molecule Bioanalytical Service market research.
The global large molecule bioanalytical service market refers to the market for specialized analytical services related to the analysis and characterization of large molecules, such as proteins, antibodies, peptides, and nucleic acids. These services are crucial in various stages of drug development, from preclinical research to clinical trials and post-marketing studies, to ensure the safety, efficacy, and quality of large molecule therapeutics. The large molecule bioanalytical service market is driven by several factors. Firstly, the increasing demand for biopharmaceuticals and biologics has generated a need for robust analytical methods to assess the pharmacokinetics, metabolism, and immunogenicity of these complex molecules. As large molecule therapeutics become more prevalent in treating various diseases, the demand for bioanalytical services to support their development and regulatory approval is on the rise. Secondly, regulatory agencies across the world, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have stringent guidelines and requirements for the characterization and analysis of large molecule drugs. These regulations necessitate the use of validated and robust bioanalytical methods to generate accurate and reliable data. Hence, pharmaceutical and biotechnology companies rely on specialized bioanalytical service providers with expertise in large molecule analysis to meet these regulatory requirements. Thirdly, advancements in technology and analytical techniques have expanded the capabilities of large molecule bioanalysis. Techniques such as liquid chromatography-mass spectrometry (LC-MS), enzyme-linked immunosorbent assay (ELISA), and ligand binding assays (LBAs) have enabled more precise and sensitive analysis of large molecules. The availability of these advanced technologies has further fueled the demand for specialized bioanalytical services. In terms of market segmentation, the large molecule bioanalytical service market can be divided based on the type of service provided, such as method development, validation, sample analysis, and pharmacokinetic analysis. Service providers in this market offer tailored solutions to meet the specific needs of drug developers and research organizations. Geographically, North America dominates the global large molecule bioanalytical service market, owing to the presence of major pharmaceutical and biotechnology companies, well-established research infrastructure, and stringent regulatory standards. Europe is also a significant market for these services, supported by the presence of top pharmaceutical companies and a robust clinical research environment. Emerging economies in Asia Pacific and Latin America are witnessing growth in the market as the biopharmaceutical industry expands and regulatory frameworks strengthen.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Large Molecule Bioanalytical Service market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Intertek Group plc.
Solvias AG
Bio-Techne Corporation
Wyatt Technology Corporation
Precision NanoSystems
Verder
Halo Labs
Charles River Laboratories International, Inc.
Avomeen
Merck KGaA
Cergentis B.V.
Laboratory Corporation of America Holdings
SCIEX
F. Hoffmann-La Roche AG
Bio-Rad Laboratories, Inc.
Segment by Type
Pharmacokinetic (PK) Testing
Pharmacodynamics (PD) Testing
Immunogenicity Testing
Biomarker Assay
Segment by Application
Online Sales
Offline Sales
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Large Molecule Bioanalytical Service report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Large Molecule Bioanalytical Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Pharmacokinetic (PK) Testing
1.2.3 Pharmacodynamics (PD) Testing
1.2.4 Immunogenicity Testing
1.2.5 Biomarker Assay
1.3 Market by Application
1.3.1 Global Large Molecule Bioanalytical Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Online Sales
1.3.3 Offline Sales
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Large Molecule Bioanalytical Service Market Perspective (2018-2029)
2.2 Large Molecule Bioanalytical Service Growth Trends by Region
2.2.1 Global Large Molecule Bioanalytical Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Large Molecule Bioanalytical Service Historic Market Size by Region (2018-2023)
2.2.3 Large Molecule Bioanalytical Service Forecasted Market Size by Region (2024-2029)
2.3 Large Molecule Bioanalytical Service Market Dynamics
2.3.1 Large Molecule Bioanalytical Service Industry Trends
2.3.2 Large Molecule Bioanalytical Service Market Drivers
2.3.3 Large Molecule Bioanalytical Service Market Challenges
2.3.4 Large Molecule Bioanalytical Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Large Molecule Bioanalytical Service Players by Revenue
3.1.1 Global Top Large Molecule Bioanalytical Service Players by Revenue (2018-2023)
3.1.2 Global Large Molecule Bioanalytical Service Revenue Market Share by Players (2018-2023)
3.2 Global Large Molecule Bioanalytical Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Large Molecule Bioanalytical Service Revenue
3.4 Global Large Molecule Bioanalytical Service Market Concentration Ratio
3.4.1 Global Large Molecule Bioanalytical Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Large Molecule Bioanalytical Service Revenue in 2022
3.5 Large Molecule Bioanalytical Service Key Players Head office and Area Served
3.6 Key Players Large Molecule Bioanalytical Service Product Solution and Service
3.7 Date of Enter into Large Molecule Bioanalytical Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Large Molecule Bioanalytical Service Breakdown Data by Type
4.1 Global Large Molecule Bioanalytical Service Historic Market Size by Type (2018-2023)
4.2 Global Large Molecule Bioanalytical Service Forecasted Market Size by Type (2024-2029)
5 Large Molecule Bioanalytical Service Breakdown Data by Application
5.1 Global Large Molecule Bioanalytical Service Historic Market Size by Application (2018-2023)
5.2 Global Large Molecule Bioanalytical Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Large Molecule Bioanalytical Service Market Size (2018-2029)
6.2 North America Large Molecule Bioanalytical Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Large Molecule Bioanalytical Service Market Size by Country (2018-2023)
6.4 North America Large Molecule Bioanalytical Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Large Molecule Bioanalytical Service Market Size (2018-2029)
7.2 Europe Large Molecule Bioanalytical Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Large Molecule Bioanalytical Service Market Size by Country (2018-2023)
7.4 Europe Large Molecule Bioanalytical Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Large Molecule Bioanalytical Service Market Size (2018-2029)
8.2 Asia-Pacific Large Molecule Bioanalytical Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Large Molecule Bioanalytical Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Large Molecule Bioanalytical Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Large Molecule Bioanalytical Service Market Size (2018-2029)
9.2 Latin America Large Molecule Bioanalytical Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Large Molecule Bioanalytical Service Market Size by Country (2018-2023)
9.4 Latin America Large Molecule Bioanalytical Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Large Molecule Bioanalytical Service Market Size (2018-2029)
10.2 Middle East & Africa Large Molecule Bioanalytical Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Large Molecule Bioanalytical Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Large Molecule Bioanalytical Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Intertek Group plc.
11.1.1 Intertek Group plc. Company Detail
11.1.2 Intertek Group plc. Business Overview
11.1.3 Intertek Group plc. Large Molecule Bioanalytical Service Introduction
11.1.4 Intertek Group plc. Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.1.5 Intertek Group plc. Recent Development
11.2 Solvias AG
11.2.1 Solvias AG Company Detail
11.2.2 Solvias AG Business Overview
11.2.3 Solvias AG Large Molecule Bioanalytical Service Introduction
11.2.4 Solvias AG Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.2.5 Solvias AG Recent Development
11.3 Bio-Techne Corporation
11.3.1 Bio-Techne Corporation Company Detail
11.3.2 Bio-Techne Corporation Business Overview
11.3.3 Bio-Techne Corporation Large Molecule Bioanalytical Service Introduction
11.3.4 Bio-Techne Corporation Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.3.5 Bio-Techne Corporation Recent Development
11.4 Wyatt Technology Corporation
11.4.1 Wyatt Technology Corporation Company Detail
11.4.2 Wyatt Technology Corporation Business Overview
11.4.3 Wyatt Technology Corporation Large Molecule Bioanalytical Service Introduction
11.4.4 Wyatt Technology Corporation Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.4.5 Wyatt Technology Corporation Recent Development
11.5 Precision NanoSystems
11.5.1 Precision NanoSystems Company Detail
11.5.2 Precision NanoSystems Business Overview
11.5.3 Precision NanoSystems Large Molecule Bioanalytical Service Introduction
11.5.4 Precision NanoSystems Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.5.5 Precision NanoSystems Recent Development
11.6 Verder
11.6.1 Verder Company Detail
11.6.2 Verder Business Overview
11.6.3 Verder Large Molecule Bioanalytical Service Introduction
11.6.4 Verder Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.6.5 Verder Recent Development
11.7 Halo Labs
11.7.1 Halo Labs Company Detail
11.7.2 Halo Labs Business Overview
11.7.3 Halo Labs Large Molecule Bioanalytical Service Introduction
11.7.4 Halo Labs Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.7.5 Halo Labs Recent Development
11.8 Charles River Laboratories International, Inc.
11.8.1 Charles River Laboratories International, Inc. Company Detail
11.8.2 Charles River Laboratories International, Inc. Business Overview
11.8.3 Charles River Laboratories International, Inc. Large Molecule Bioanalytical Service Introduction
11.8.4 Charles River Laboratories International, Inc. Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.8.5 Charles River Laboratories International, Inc. Recent Development
11.9 Avomeen
11.9.1 Avomeen Company Detail
11.9.2 Avomeen Business Overview
11.9.3 Avomeen Large Molecule Bioanalytical Service Introduction
11.9.4 Avomeen Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.9.5 Avomeen Recent Development
11.10 Merck KGaA
11.10.1 Merck KGaA Company Detail
11.10.2 Merck KGaA Business Overview
11.10.3 Merck KGaA Large Molecule Bioanalytical Service Introduction
11.10.4 Merck KGaA Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.10.5 Merck KGaA Recent Development
11.11 Cergentis B.V.
11.11.1 Cergentis B.V. Company Detail
11.11.2 Cergentis B.V. Business Overview
11.11.3 Cergentis B.V. Large Molecule Bioanalytical Service Introduction
11.11.4 Cergentis B.V. Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.11.5 Cergentis B.V. Recent Development
11.12 Laboratory Corporation of America Holdings
11.12.1 Laboratory Corporation of America Holdings Company Detail
11.12.2 Laboratory Corporation of America Holdings Business Overview
11.12.3 Laboratory Corporation of America Holdings Large Molecule Bioanalytical Service Introduction
11.12.4 Laboratory Corporation of America Holdings Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.12.5 Laboratory Corporation of America Holdings Recent Development
11.13 SCIEX
11.13.1 SCIEX Company Detail
11.13.2 SCIEX Business Overview
11.13.3 SCIEX Large Molecule Bioanalytical Service Introduction
11.13.4 SCIEX Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.13.5 SCIEX Recent Development
11.14 F. Hoffmann-La Roche AG
11.14.1 F. Hoffmann-La Roche AG Company Detail
11.14.2 F. Hoffmann-La Roche AG Business Overview
11.14.3 F. Hoffmann-La Roche AG Large Molecule Bioanalytical Service Introduction
11.14.4 F. Hoffmann-La Roche AG Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.14.5 F. Hoffmann-La Roche AG Recent Development
11.15 Bio-Rad Laboratories, Inc.
11.15.1 Bio-Rad Laboratories, Inc. Company Detail
11.15.2 Bio-Rad Laboratories, Inc. Business Overview
11.15.3 Bio-Rad Laboratories, Inc. Large Molecule Bioanalytical Service Introduction
11.15.4 Bio-Rad Laboratories, Inc. Revenue in Large Molecule Bioanalytical Service Business (2018-2023)
11.15.5 Bio-Rad Laboratories, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
